TABLE OF CONTENTS
|  |  |  | Volume 21, Issue 3 (March 2014) |  | In this issue Original Articles
Also new    AOP
| |  |  | Original Articles | Top |  | Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNα/Syn3 treatment in a phase l studyW F Benedict, M Fisher, X-Q Zhang, Z Yang, M F Munsell and C N P Dinney Cancer Gene Ther 2014 21: 91-94; advance online publication, February 7, 2014; 10.1038/cgt.2014.1 Abstract | Full Text |  |  |  | CD40L gene therapy tilts the myeloid cell profile and promotes infiltration of activated T lymphocytesL Liljenfeldt, L C Dieterich, A Dimberg, S M Mangsbo and A S I Loskog Cancer Gene Ther 2014 21: 95-102; advance online publication, January 31, 2014; 10.1038/cgt.2014.2 Abstract | Full Text |  |  |  | In vitro and in vivo radiosensitization of human glioma U251 cells induced by upregulated expression of SLC22A18S-H Chu, Z-M Zhou, S Karri, Z-Q Li and J-M Zhao Cancer Gene Ther 2014 21: 103-109; advance online publication, January 31, 2014; 10.1038/cgt.2014.4 Abstract | Full Text |  |  |  | Lower Ras expression as an independent predictor of patient outcomes in lung cancer treated with bevacizumab plus chemotherapyS J An, Y S Huang, Z H Chen, J F Han, J J Yang, Q Zhou, Z Xie, Y Yang, H H Yan and Y L Wu Cancer Gene Ther 2014 21: 110-114; advance online publication, February 28, 2014; 10.1038/cgt.2014.5 Abstract | Full Text |  |  |  | Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3J Musil, L Kutinova, K Zurkova, P Hainz, K Babiarova, J Krystofova and S Nemeckova Cancer Gene Ther 2014 21: 115-125; advance online publication, February 21, 2014; 10.1038/cgt.2014.6 Abstract | Full Text |  |  |  | Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenovirusesM Takagi-Kimura, T Yamano, M Tagawa and S Kubo Cancer Gene Ther 2014 21: 126-132; advance online publication, February 28, 2014; 10.1038/cgt.2014.7 Abstract | Full Text |  |  |  | Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growthT Chen, J Xiong, C Yang, L Shan, G Tan, L Yu and Y Tan Cancer Gene Ther 2014 21: 133-138; advance online publication, February 28, 2014; 10.1038/cgt.2014.8 Abstract | Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment